
Endometriosis Treatment Market by Drug Type (GnRH Analogues, LNR-IUDS, NSAIDs), Treatment Type (Hormonal Therapy, Pain Management), Distribution Channel - Global Forecast 2024-2030
Description
Endometriosis Treatment Market by Drug Type (GnRH Analogues, LNR-IUDS, NSAIDs), Treatment Type (Hormonal Therapy, Pain Management), Distribution Channel - Global Forecast 2024-2030
The Endometriosis Treatment Market size was estimated at USD 2.84 billion in 2023 and expected to reach USD 3.05 billion in 2024, at a CAGR 7.36% to reach USD 4.68 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Endometriosis Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Endometriosis Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Endometriosis Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bayer AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Ipsen Pharma, Medtronic PLC, Merck & Co., Inc., Myovant Sciences GmbH, Neurocrine Biosciences, Inc., Orphagen Pharmaceuticals, Inc., Sanofi S.A., Stryker Corporation, and Vital Health Endometriosis Center.
Market Segmentation & Coverage
This research report categorizes the Endometriosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
Drug Type
GnRH Analogues
LNR-IUDS
NSAIDs
Oral Contraceptives
Progestins
Treatment Type
Hormonal Therapy
Pain Management
Distribution Channel
E-Commerce
Hospital
Pharmacies
Retail Pharmacies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Endometriosis Treatment Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Endometriosis Treatment Market?
3. What are the technology trends and regulatory frameworks in the Endometriosis Treatment Market?
4. What is the market share of the leading vendors in the Endometriosis Treatment Market?
5. Which modes and strategic moves are suitable for entering the Endometriosis Treatment Market?PDF E-mail From Publisher (2-5)Users License
Table of Contents
194 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Endometriosis Treatment Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing prevalence rate of endometriosis
- 5.1.1.2. Increase in the female population within the reproductive age
- 5.1.1.3. Rising presence of novel drugs worldwide
- 5.1.2. Restraints
- 5.1.2.1. Lack of non-invasive diagnostics
- 5.1.3. Opportunities
- 5.1.3.1. Rise in research activities for development of new drugs and treatment methodologies
- 5.1.3.2. Rising use nanotechnology to develop new treatment for endometriosis
- 5.1.4. Challenges
- 5.1.4.1. Presence of alternative treatment such as Intrauterine Systems (IUS)
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Endometriosis Treatment Market, by Drug Type
- 6.1. Introduction
- 6.2. GnRH Analogues
- 6.3. LNR-IUDS
- 6.4. NSAIDs
- 6.5. Oral Contraceptives
- 6.6. Progestins
- 7. Endometriosis Treatment Market, by Treatment Type
- 7.1. Introduction
- 7.2. Hormonal Therapy
- 7.3. Pain Management
- 8. Endometriosis Treatment Market, by Distribution Channel
- 8.1. Introduction
- 8.2. E-Commerce
- 8.3. Hospital
- 8.4. Pharmacies
- 8.5. Retail Pharmacies
- 9. Americas Endometriosis Treatment Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Endometriosis Treatment Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Endometriosis Treatment Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. AbbVie Inc.
- 13.1.3. Astellas Pharma Inc.
- 13.1.4. Bayer AG
- 13.1.5. F. Hoffmann-La Roche Ltd
- 13.1.6. GlaxoSmithKline PLC
- 13.1.7. Ipsen Pharma
- 13.1.8. Medtronic PLC
- 13.1.9. Merck & Co., Inc.
- 13.1.10. Myovant Sciences GmbH
- 13.1.11. Neurocrine Biosciences, Inc.
- 13.1.12. Orphagen Pharmaceuticals, Inc.
- 13.1.13. Sanofi S.A.
- 13.1.14. Stryker Corporation
- 13.1.15. Vital Health Endometriosis Center
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. ENDOMETRIOSIS TREATMENT MARKET RESEARCH PROCESS
- FIGURE 2. ENDOMETRIOSIS TREATMENT MARKET SIZE, 2023 VS 2030
- FIGURE 3. ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ENDOMETRIOSIS TREATMENT MARKET DYNAMICS
- FIGURE 7. ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
- FIGURE 8. ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
- FIGURE 10. ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 12. ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ENDOMETRIOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. ENDOMETRIOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.